Meet the Team
John Ramunas
Founder & CEO
Stanford PhD, Co-inventor, Decade of experience with mRNA for therapeutic applications. Thesis title: Telomere extension to extend human healthspan.
Glenn Markov
Founder & COO
Stanford PhD, Decade of experience in genetics and epigenetics of cellular reprogramming.
Suzana Tulac
Director, Translational Development and Project Management
Molecular and Cellular Biology, Functional Genomics
Stanford trained PhD with deep experience in both research and production environments.
Dan Chambers
Chief Medical Officer
MBBS MRCP FRACP MD FQA, Internationally-recognized thoracic transplant physician and translational clinician researcher, Clinical Professor at U. of Queensland, Executive Director of Research at Australia’s largest health service, and heads one of the world’s largest clinical trials programs in lung fibrosis, KOL on role of short telomeres in lung fibrosis.
Guo Tao
Director, Scientific Research
MD, PhD. Over 20 years’ experience in biomedical and translational research focusing on liver and intestinal diseases at Stanford University.
Tanya Velasco
Life Science Research Associate II
BSc in Cell and Molecular Biology.
Robin Holbrook
Director of Finance and Administration
Stanford AB in Cultural Anthropology, 30+ years of F&A experience supporting research excellence at Stanford School of Medicine.
Victor Knopov
Chemistry, Manufacturing, and Controls (CMC)
PhD, 11 years as Director of Manufacturing at Arbutus precursor Tekmira, Biologics CMC head at Nitto Denko, multiple other companies.
Advisors
Patty Limphong
PhD
Former Director at Arcturus Therapeutics in mRNA LNP development.
David Pepperl
PhD
Pharmacologist and toxicologist, over 100 INDs
Bill Bradford
MD, PhD
Led Pirfenidone approval, entrepreneur, fibrotic disease expert.
Helen Blau
Founder & Advisor
Co-inventor, Professor at Stanford University, discovered that short telomeres underlie the fatal etiology of multiple monogenic diseases.
Larry Couture
PhD
>100 INDs as the founder of the first biologics translational department at City of Hope, Los Angeles.
Christine Kim Garcia
MD, PhD
Chief of Pulmonary, Allergy and Critical Care Medicine and Professor of Medicine at Columbia University Irving Medical Center, KOL on role of short telomeres in pulmonary fibrosis.
Paul Noble
MD
Professor and Chair Pulmonary Medicine at Cedars Sinai, Leading Clinician-Researcher in IPF.
Shamik Ghosh
VP Preclinical Development
PHD, MBA, Led two startups from bench to clinic and aquisition, respectively.
Contact Us
Employment inquiries: jobs@rejuvenationtech.com
Investor inquiries: invest@rejuvenationtech.com
General inquiries: info@rejuvenationtech.com
